✦ LIBER ✦

Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients

✍ Scribed by Alexander H. Toledo; Laura Hendrix; Valorie Buchholz; Erin Fisher; Kimberly Newton; Courtney Smith; David A. Gerber

Book ID: 115092094
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 95 KB
Volume: 26
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2011.01444.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved gastrointestinal symptom burden

Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children

✍ Lars Pape; Thurid Ahlenstiel; Martin Kreuzer; Jochen H. H. Ehrich 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Renal Transplant Patients With Gastroint

Renal Transplant Patients With Gastrointestinal Intolerability to Mycophenolate Mofetil: Conversion to Enteric-Coated Mycophenolate Sodium

✍ N. Calvo; A.I. Sanchez-Fructuoso; J. Conesa; A. Moreno; A. Barrientos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Switching From Mycophenolate Mofetil to

Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications

✍ L. Barrera-Pulido; J.M. Álamo-Martínez; L.M. Marín-Gómez; G. Suárez-Artacho; C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Conversion from mycophenolate mofetil to

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

✍ Jérôme Dumortier; Marie-Claude Gagnieu; Janine Salandre; Olivier Guillaud; Phili 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients

Successful Conversion From Mycophenolate

Successful Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium (Myfortic) in Liver Transplant Patients With Gastrointestinal Side Effects

✍ G. Robaeys; D. Cassiman; C. Verslype; D. Monbaliu; R. Aerts; J. Pirenne; F. Neve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 587 KB

229 SUCCESSFUL CONVERSION FROM MYCOPHENO

229 SUCCESSFUL CONVERSION FROM MYCOPHENOLATE MOFETIL TO ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC®) IN LIVER TRANSPLANT PATIENTS WITH GASTROINTESTINAL SIDE EFFECTS

✍ G. Robaeys; D. Cassiman; C. Verslype; D. Monbaliu; R. Aerts; J. Pirenne; F. Neve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB